Aurélien Delluc

The Ottawa Hospital, Division of Haematology, Ottawa, Canada

Posts

Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy
Risk Factors

Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy

Approximately 4% of cancer patients have non-valvular atrial fibrillation (NVAF) and require anticoagulation for prophylaxis against embolic stroke.

Read More